Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

Blood (2017) 130 (11): 1315–1326.

https://doi.org/10.1182/blood-2017-02-766691

Published: 2017

Includes: Supplemental data

Journal Articles

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

J.C. Kluin-Nelemans, E. Hoster, J. Walewski, MD, S. Stilgenbauer, M.D., C. H. Geisler, C. Gisselbrecht, MD, U. Vehling-Kaiser, MD, J. K. Doorduijn, MD, M. Trneny, MD, B. Coiffier, MD, R. Forstpointner, MD, H. Tilly, MD, L. Kanz, MD, M. Szymczyk, MD, O. Hermine, MD, PhD, W. Klapper, MD, W. Hiddemann, MD, M. Unterhalt, PhD, M. H. Dreyling, MD

Blood (2011) 118 (21): 439.

https://doi.org/10.1182/blood.V118.21.439.439

Published: 2011

Journal Articles

Reduced Intensity Allogeneic Stem Cell Transplantation for Follicular Lymphoma Results in An Improved Progression Free Survival When Compared to Autologous Stem Cell Transplantation. An Analysis from the Lymphoma Working Party of the EBMT

Stephen P Robinson, Carmen Canals, Didier Blaise, MD, Kirsty Thomson, Robert Foa, Arturo Iriondo Atienza, Jean-Luc Harousseau, Catherine Cordonnier, MD, Gordon Cook, MD, PhD, Jean-Pierre Jouet, MD, Jean-Yves Cahn, MD, PhD, Charles Crawley, Michel Attal, MD, Marek Trneny, MD, PhD, H. Tilly, Anna Sureda, MD

Blood (2008) 112 (11): 458.

https://doi.org/10.1182/blood.V112.11.458.458

Published: 2008

Journal Articles

Long Term Follow-up of the GELF86 French and Belgian Trials: Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission

E. Bachy, P. Brice, M. Fournier, H. Tilly, C. Haioun, N. Brousse, S. Le Gouil, A. Bosly, B. Coiffier, C. Gisselbrecht, P. Solal-Celigny, G. Salles

Blood (2008) 112 (11): 2590.

https://doi.org/10.1182/blood.V112.11.2590.2590

Published: 2008

Journal Articles

Outcome of Relapsed AML Patients Aged between 50 and 70: The ALFA Group Experience (ALFA 9801 Study).

F. Merabet, N. Boissel, O. Reman, Jean-Henri Bourhis, B. Quesnel, S. Rigaudeau, C. Cordonnier, D. Bordessoule, H. Tilly, S. Corm, M. Michallet, J.M. Miclea, X. Thomas, S. Chevret, P. Fenaux, S. Castaigne

Blood (2007) 110 (11): 1857.

https://doi.org/10.1182/blood.V110.11.1857.1857

Published: 2007

Journal Articles

Significant Correlation between Survival Endpoints and Exposure to Ofatumumab (HuMax-CD20) in Chronic Lymphocytic Leukemia.

Bertrand Coiffier, H. Tilly, L.M. Pedersen, T. Plesner, H. Frederiksen, M.H.J. van Oers, J. Wooldridge, J.S. Kloczko, J. Holowiecki, A. Hellmann, J. Walewski, M. Flensburg, J. Petersen, T. Robak

Blood (2006) 108 (11): 2842.

https://doi.org/10.1182/blood.V108.11.2842.2842

Published: 2006

Journal Articles

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study.

R. Delarue, N. Mounier, C. Haioun, B. Coiffier, C. Gisselbrecht, H. Ghesquieres, P. Lederlin, M. Blanc, C. Recher, O. Hermine, F. Reyes, H. Tilly, A. Bosly

Blood (2006) 108 (11): 2436.

https://doi.org/10.1182/blood.V108.11.2436.2436

Published: 2006

Journal Articles

HuMax CD20 Fully Human Monoclonal Antibody in Chronic Lymphocytic Leuchemia. Early Results from an Ongoing Phase I/II Clinical Trial.

Bertrand Coiffier, H. Tilly, L. M. Pedersen, T. Plesner, H. Frederiksen, M.H.J. van Oers, J. Wooldridge, J. Kloczko, J. Holowiecki, A. Hellmann, J. J. Walewski, M.F. Flensburg, J. Petersen, T. Robak

Blood (2005) 106 (11): 448.

https://doi.org/10.1182/blood.V106.11.448.448

Published: 2005

Journal Articles

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

Georges Fillet, C. Bonnet, N. Mounier, G. Ganem, T. Molina, C. Thieblemont, C. Fermé, B. Quesnel, C. Martin, C. Gisselbrecht, H. Tilly, F. Reyes

Blood (2005) 106 (11): 15.

https://doi.org/10.1182/blood.V106.11.15.15

Published: 2005

Journal Articles

Late Onset, Acute Severe Neutropenia in Patients Treated with Rituximab for B-Cell Lymphoproliferation.

Philippe Solal-Celigny, md, F. Morschhauser, md, O. Tournilhac, md, C. Foussard, md, O. Fitoussi, md, A. Lillo-Le Louet, md, P. Brice, md, T. Lamy, md, H. Tilly, md, E. Gyan, md, Ph. Agape, md, E. Suc, md, A. Saad, md, A. Devidas, md, M. Blanc, md, A. Le Rol, md, P. Galanaud, md, J. Y. Muller, md, E. Voog, md

Blood (2004) 104 (11): 4607.

https://doi.org/10.1182/blood.V104.11.4607.4607

Published: 2004

Journal Articles

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

B. Coiffier, C. Haioun, N. Ketterer, A. Engert, H. Tilly, D. Ma, P. Johnson, A. Lister, M. Feuring- Buske, J.A. Radford, R. Capdeville, V. Diehl, F. Reyes

Blood (1998) 92 (6): 1927–1932.

https://doi.org/10.1182/blood.V92.6.1927

Published: 1998

Journal Articles

Prognostic value of chromosomal abnormalities in follicular lymphoma

H Tilly, A Rossi, A Stamatoullas, B Lenormand, C Bigorgne, A Kunlin, M Monconduit, C Bastard

Blood (1994) 84 (4): 1043–1049.

https://doi.org/10.1182/blood.V84.4.1043.1043

Published: 1994

Journal Articles

LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients

C Bastard, C Deweindt, JP Kerckaert, B Lenormand, A Rossi, F Pezzella, C Fruchart, C Duval, M Monconduit, H Tilly

Blood (1994) 83 (9): 2423–2427.

https://doi.org/10.1182/blood.V83.9.2423.2423

Published: 1994

Journal Articles

Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]

C Gisselbrecht, D Maraninchi, JL Pico, N Milpied, B Coiffier, M Divine, P Tiberghien, A Bosly, H Tilly, O Boulat

Blood (1994) 83 (8): 2081–2085.

https://doi.org/10.1182/blood.V83.8.2081.2081

Published: 1994

Journal Articles

Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia

S Castaigne, P Lefebvre, C Chomienne, E Suc, F Rigal-Huguet, C Gardin, A Delmer, E Archimbaud, H Tilly, M Janvier

Blood (1993) 82 (12): 3560–3563.

https://doi.org/10.1182/blood.V82.12.3560.3560

Published: 1993

Journal Articles

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

P Fenaux, S Castaigne, H Dombret, E Archimbaud, M Duarte, P Morel, T Lamy, H Tilly, A Guerci, F Maloisel

Blood (1992) 80 (9): 2176–2181.

https://doi.org/10.1182/blood.V80.9.2176.2176

Published: 1992

Journal Articles

Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma [see comments]

C Bastard, H Tilly, B Lenormand, C Bigorgne, D Boulet, A Kunlin, M Monconduit, H Piguet

Blood (1992) 79 (10): 2527–2531.

https://doi.org/10.1182/blood.V79.10.2527.2527

Published: 1992

Journal Articles

Cytogenetic studies in untreated Hodgkin's disease

H Tilly, C Bastard, T Delastre, C Duval, M Bizet, B Lenormand, JP Dauce, M Monconduit, H Piguet

Blood (1991) 77 (6): 1298–1304.

https://doi.org/10.1182/blood.V77.6.1298.1298

Published: 1991

Journal Articles

Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?

S Castaigne, MT Daniel, H Tilly, P Herait, L Degos

Blood (1983) 62 (1): 85–86.

https://doi.org/10.1182/blood.V62.1.85.85

Published: 1983

NARROW

FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

Reduced Intensity Allogeneic Stem Cell Transplantation for Follicular Lymphoma Results in An Improved Progression Free Survival When Compared to Autologous Stem Cell Transplantation. An Analysis from the Lymphoma Working Party of the EBMT

Long Term Follow-up of the GELF86 French and Belgian Trials: Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission

Outcome of Relapsed AML Patients Aged between 50 and 70: The ALFA Group Experience (ALFA 9801 Study).

Significant Correlation between Survival Endpoints and Exposure to Ofatumumab (HuMax-CD20) in Chronic Lymphocytic Leukemia.

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study.

HuMax CD20 Fully Human Monoclonal Antibody in Chronic Lymphocytic Leuchemia. Early Results from an Ongoing Phase I/II Clinical Trial.

No Role for Chemoradiotherapy When Compared with Chemotherapy Alone in Elderly Patients with Localized Low Risk Aggressive Lymphoma: Final Results of the LNH93-4 GELA Study.

Late Onset, Acute Severe Neutropenia in Patients Treated with Rituximab for B-Cell Lymphoproliferation.

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

Prognostic value of chromosomal abnormalities in follicular lymphoma

LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients

Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]

Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma [see comments]

Cytogenetic studies in untreated Hodgkin's disease

Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only